Clinical Trials Directory

Trials / Completed

CompletedNCT04212806

French Validation of Axial Spondyloarthritis Questionnaires (Val-SpA)

French Linguistic Validation of Questionnaires for Patients With Axial Spondyloarthritis

Status
Completed
Phase
Study type
Observational
Enrollment
5 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim is to do a French linguistic validation of three questionnaires used in axial Spondyloarthritis (BASFI, BAS-G, Dougados Functional Index). In order to validate the questionnaires, a prospective, qualitative, observational and monocentric study will be conducted.

Detailed description

Axial spondyloarthritis (SpA) is a chronic rheumatic diseases affecting axial skeleton and sacro-iliac joints. SpA can have functional consequences, often assessed with the Bath Ankylosing Spondylitis Functional Index (BASFI), the Dougados functional index, or more globally with the Bath Ankylosing Spondylitis Global (BAS-G). If these questionnaires are validated in English, there are not validated in French. The aim is to do a french linguistic validation of these questionnaires. A translation, reconciliation and retro-translation will be conducted for each of the questionnaires by two bilingual translators. The last version of each questionnaire will be then validated by clinicians experts in SpA. The version will be further validated by 5 patients. If necessary and if changes occured on the version of the questionnaire, another version will be validated by 5 other patients until full understanding is obtained.

Conditions

Timeline

Start date
2020-01-27
Primary completion
2020-09-07
Completion
2020-12-31
First posted
2019-12-30
Last updated
2022-11-23

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04212806. Inclusion in this directory is not an endorsement.